In the present study, we determined the effects of oral administration of L-and D-aspartate (L-Asp and D-Asp) on food intake over a period of 2 h after the administration, as well as its effects on the concentration of L-and D-Asp in the brain and plasma. Chicks were orally administered different levels ( 
Introduction
Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its action via the activation of several subtypes of excitatory amino acid (EAA) receptors including the N-methyl-D-aspartate glutamate (NMDA) receptor (Kubrusly et al., 1998) . Past studies have determined the brain neurochemical systems that regulate food intake, and have identified a number of neurotransmitters that appear to contribute to this behavior. For example, L-aspartate (L-Asp) and its enantiomer Daspartate (D-Asp) are EAA members, and have been well documented as regulators of the endocrine system (Estienne et al., 1997; D'Aniello et al., 2000a,b) ; as such, they may affect the growth performance of domestic animals.
D-Asp, synthesized from L-Asp by aspartate racemase, can directly stimulate the NMDA receptor (D'Aniello et al., 2000a; Woloskor et al., 2000) . Additionally, numerous studies involving pharmacological treatments have investigated the role of glutamate in the regulation of appetitive behavior in mammals. Intracerebroventricular (i.c.v.) administration or local administration of glutamate (Reddy et al., 1986; Ritter and Stone, 1987; Wandji et al., 1989) or the glutamate agonist, NMDA, induced hyperphagia, but these effects were not elicited by the administration of kainate or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) in chicks (Bungo et al., 2011) . These orexigenic effects of glutamate and NMDA appear to be mediated not only by NMDA receptors but also by other EAA receptor subtypes (Da Silva et al., 2003) . Although these reports suggest that L-Asp and D-Asp might also have an orexigenic effect in chicks through the activation of the NMDA receptor in the brain, Bungo et al. (2002) demonstrated that i. c. v. injection of L-Asp as a glutamate receptor agonist did not alter eating behaviors in chicks. In addition, numerous studies have also investigated the role of D-Asp in the regulation of food intake in mammals. For instance, reported that orally administered D-Asp caused significant decreases in body weight and the weight of the liver, as well as in daily food intake in rats. As with mammals, it was reported that D-Asp in the diet reduced food intake in chicks (Maruyama et al., 1972) . In fact, Land D-Asp have been shown to exist in various brain regions of the chicken (Neidle and Dunlop, 1990 ) and the pigeon (Kera et al., 1996) . However, little is known about the mechanisms underlying the effects of either L-or D-Asp on food intake in chicks. The purpose of the present study was to examine the effects of the oral administration of different doses of L-and D-Asp on food intake in chicks. We explored this issue further by also investigating the effects of these treatments on the concentration of L-and D-Asp in plasma and the brain. The effects of L-Asp and D-Asp on levels of brain monoamines (dopamine [DA] , serotonin and their metabolites) were also investigated, since these monoamines have been recognized as regulators of behavior and/or of stress responses in chicks (Zhang et al., 2003; Saito et al., 2004; Hamasu et al., 2009 ).
Materials and Methods

Animals and Drugs
One-day-old layer chicks were purchased from a local hatchery (Murata hatchery, Fukuoka, Japan) and housed in a wire-meshed cage (50×35×33 cm) in a group (20-25 birds) at a constant temperature of 30±1℃ and with continuous light until the day of the experiment. Chicks were all of the same age and were housed without an adult. Food (AX, Toyohashi Feed and Mills Co. Ltd., Aichi, Japan) and water were available ad libitum. One day before the experiment, chicks (4 days old) were reared individually and assigned to treatment groups on the basis of their body weight in order to produce uniform treatment groups. The number of animals used in each group was kept to the minimum (n＝8) that would still ensure adequate statistical power. This study was performed in accordance with the guidelines for animal experiments carried out in the Faculty of Agriculture and in the Graduate Course of Kyushu University, and adhered to Law no. 105 and Notification no. 6 of the government.
L-and D-Asp were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Procedure for Oral Administration Test
Following a habituation period, chicks were randomly selected and divided into four groups each consisting of 8 chicks. The birds were reared individually in experimental cages and had ad libitum access to diet up to the time of the experiments. On the day of the experiment, each chick (5 days old) was orally administered distilled water or L-Asp (Experiment 1) / D-Asp (Experiment 2) solutions by the elastic plastic needle on small syringe. Finkelstein et al. (1983) determined plasma L-Asp concentration at 0, 15, 30, 45, 60, and 120 min after applying L-Asp at 0, 1.88, 3.76, 4.89, 5.64 and 7.52 mmol/kg body weight. Plasma L-Asp concentration was hardly influenced by 1.88 and 3.76 mmol/kg. Thus, we applied here 3.75, 7.5 and 15.0 mmol/kg of L-Asp and D-Asp as the lowest, medium and highest levels, respectively.
The birds were fed ad libitum diets for 2 h immediately after the treatment. Food intake (at 30, 60 and 120 min) was determined by measuring the reduction in the amount of food consumed from a pre-weighed feeder. The weight of the feeder was measured using an electric digital balance. At the end of the experiments, birds were decapitated following anesthesia with isoflurane (Mylan Inc., Japan). Blood samples were collected in heparinized tubes and centrifuged for 4 min at 4℃ at 10,000 g, and the plasma was collected and stored at −80℃ until analysis took place.
Analysis of Monoamines in the Brain
In Experiments 1 and 2, the brains were carefully taken from the skulls and placed on a cold glass dish. We collected the brain samples on the glass dish which was kept on dry ice. Two parts (the telencephalon and the diencephalon) were dissected from each brain, and were stored at −80℃ until analysis took place. The telencephalon and diencephalon were identified according to the brain atlas of the chick (Kuenzel and Masson, 1988) . Telencephalon collected is part of the brain which excludes diencephalon and mesencephalon. Diencephalon was divided by cutting between stria medullaris and posterior commissure. Diencephalon includes hypothalamus and thalamus. Monoamines (DA, 5-HT) and their metabolites, homovanillic acid (HVA), 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA), were determined in these brain regions as described elsewhere (Tomonaga et al., 2008) , with some modifications. The tissues were weighed and homogenized in a solution of 0.2 M ice-cold perchloric acid containing 0.01 mM EDTA 2Na. Samples were allowed to sit on ice for 30 min for deproteinization. The homogenate was centrifuged at 20,000 g for 15 min. Supernatants were adjusted to pH 3 with 1 M sodium acetate and were filtered through a 0.2-μm filter (Millipore, Bedford, MA, USA). A 30-μl aliquot of filtrate was analyzed using a high-performance liquid chromatography system (Eicom, Kyoto, Japan) with a 150×3.0 mm ODS column (SC-5ODS, Eicom) and an electrochemical detector (ECD-300, Eicom) at an applied potential of ＋750 mV versus an Ag/AgCl reference analytical electrode. The mobile phase was made up of an aceto-citric acid buffer (pH 3.5, 0.1 mol/l), methanol, sodium-1-octane sulfonate (0.46 mol/l) and disodium ethylenediaminetetraacetic acid (0.01 mol/l) (830:170:1.9:1). The external standard containing 100 pg/μl of each MHPG, NE, DOPAC, DA, 5HIAA, HVA and 5HT was used to identify peaks eluting in the chromatogram relating to retention time and conformation. The detection limit of the system for all monoamines was 0.1 pg/sample.
Analysis of L-and D-Asp
L-and D-Asp contents in the plasma and brains were analyzed according to the previously described method (Ohmori et al., 2011) . The supernatants that were collected during the monoamine analysis were applied for the measurement of L-and D-Asp contents in the brains. Plasma was prepared by centrifuging it at 20,000×g for 15 min at 4℃ (MX-307, Tommy, Japan), and then it was filtrated Erwan et al.: D-Aspartate and Food Intake through ultrafiltration tubes (Millipore, Bedford, USA). Each 20-μl sample of the brain or plasma was dissolved with 2 μl of 1 M NaOH and then vortexed. Both the L-and the DAsp contents were measured by a UPLC (the Acquity TM UPLC system comprised of Waters Binary Solvent Manager, Water Sample Manager and Waters FLR Detector) with an ACCQ-TAG TM ULTRA C18 1.7 μm 2.1×100 mm column (Waters Corporation, USA). The excitation and emission wavelengths for fluorescent detection of amino acids were 350 nm and 450 nm, respectively. The system was operated with a flow rate of 0.25 ml/min at 30℃. The UPLC gradient system (A＝50 mM sodium acetate (pH 5.9), B＝methanol) was 10-20% B over 3.2 min, 20% B for 1 min, 20-40% B over 3.6 min, 40% B for 1.2 min, 40-60% B over 3.8 min, 60% B for 1 min, and 60-10% B over 0.01 min. Just before the analysis in UPLC, each sample (10 μl) was transferred to a UPLC tube, and N-acetylcysteine/O-phthalaldehyde (20 μl) and a borate buffer (70 μl) were added; then it was left for 2 min in a dark room. The same method was used for the standard solutions. The plasma amino acid concentrations were expressed in nmol/ml, and the amino acid concentrations in the brains were expressed as pmol/mg wet tissue.
Statistical Analysis
A repeated-measures two-way ANOVA was applied for the analysis of food intake in both Experiments 1 and 2. For the other parameters, a two-way ANOVA was applied. Significant differences were denoted as p＜0.05. Values were presented as means±S.E.M. Statistical analysis was made using the commercially available package SAS (Version 9.0, SAS Institute, Cary, U.S. A., 2002) . All data in each group were first subjected to a Thompson rejection test to eliminate outliers (p＜0.01), and the remaining data were used for the analysis among groups.
Results
Experiment 1: Effects of Oral Administration of L-Asp on Food Intake, L-and D-Asp Contents in Plasma and the Brain, and Monoamine Levels in the Brain of Chicks
Oral administration of several doses of L-Asp did not significantly alter food intake in chicks (data not shown). Table 1 As shown in Table 4 , monoamine contents in both the diencephalon and the telencephalon were not altered by oral D-Asp.
Discussion
The concept that L-Asp is a neurotransmitter in the CNS is supported by a variety of data derived from studies involving rats: L-Asp is not only concentrated in nerve endings (Gundersen et al., 1991) , but is also localized and found accumulated in common synaptic vesicles (Gundersen et al., 1998; Fleck et al., 2001 ). Thus, this study focused on the effects of oral L-Asp and its enantiomer D-Asp on the food intake in chicks as well as the controlling mechanism of this behavior in the brain to clarify the physiological importance of L-and D-Asp in birds.
It has been reported that there is a correlation between orally administered doses of L-Asp and consequent concentrations of L-Asp in plasma in mice (Finkelstein et al., 1983; Daabees et al., 1985) . Thus, the effects of administered LAsp on plasma L-Asp levels were consistent between those previously observed for mice and those observed for chicks in Experiment 1. However, food intake did not decrease significantly when chicks were orally administered L-Asp. This result was consistent with the previous reports. Bungo et al. (2002) reported that i.c.v. injection of L-Asp failed to affect food intake at 30, 60 and 120 min in Leghorn chicks. Other supportive data are reported by Maruyama et al. (1972) , who demonstrated that a diet containing 6% L-Asp did not lead to significantly decreased growth of chicks. In the light of information mentioned above and of the results from the present study, it might be suggested that central or oral administration of L-Asp seemed to similar effects on food intake in chicks.
In Experiment 2, oral administration of D-Asp reduced the food consumption of chicks. Data from Experiment 2 indicate that oral administration of D-Asp caused in dosedependent decreases food intake at short-term (30, 60 or 120 min after oral administration). The oral administration applied here seems to have a similar result with oral longterm administration of D-Asp in rat . It is clear that D-Asp has an acute effect on decreases in food intake.
It seems to be evident from the following reports that DAsp markedly reduces food consumption. First, revealed that orally administered D-Asp caused significant decreases in body weight and in the weight of the liver, as well as in daily food intake in rats. Second, Sugahara et al. (1967) concluded that D-Asp has no nutritional value and also has a retardation effect on chick growth. Third, Maruyama et al. (1972) found that an amino acid diet containing 2% D-Asp resulted in growth depression in chicks. Finally, revealed that in rats, long-term oral administration of D-Asp caused a significant decrease in daily food intake, total body weight, and the weight of the liver and the kidneys; the concomitant oral administration of L-Asp seemed to antagonize the effect of D-Asp.
The reduced food intake following oral administration of D-Asp could be explained by four possibilities mentioned below. First, excessive D-Asp concentration may depress the food intake of chicks through unbalanced proportions of amino acids (Peng et al., 1969; Harper et al., 1970; Leung and Rogers, 1971) . Second, the reduced food intake might be the result of the depressed peristaltic action of the digestive tract that seemed to be caused by D-Asp administration (Maruyama et al., 1972) . Notably, adverse effects of DAsp are greater in chicks fed a diet containing other D-amino acids (Kamath and Berg, 1964; Marrett and Sunde, 1965) . Such effects are probably caused by a general interference in the utilization of D-amino acids (Kamath and Berg, 1964; Marrett and Sunde, 1965) . Third, the concentration of DAsp in the diencephalon increased by 6.64 times compared with the control (Table 3) ; although we do not know the exact mechanism by which D-Asp decreased food intake in proportion to the concentration of D-Asp in the brain, D-Asp may act as a regulator of feeding since a major feeding center, the hypothalamus, is present in the diencephalon. Here, we propose the fourth possibility. It has been hypothesized that opioid systems may be involved in the regulation of food intake concerned with acquisition of nutrients and in conservation and with expenditure of energy (Margules, 1979) . Although the endogenous opioid system stimulated feeding behavior in mammals (Bodnar, 1996) and birds (McCormarck and Denbow, 1988, 1989) , several other studies generally found in decreasing food intake (Kumar et al., 1971; Frenk and Rogers, 1979; Marks-Kaufman and Kanarck, 1980) . The decrease in food intake can be explained not only by the direct effect of opioid, but also by the opioid-induced release of antidiuretic hormone, arginine vasopressin (AVP) (George and Way, 1959; Huidobro, 1978) . In fact, AVP has long been known to be capable of realizing adrenocorticotropic hormone (ACTH) (Gillis and Lowry, 1979) . Previous report revealed that the injection of D-Asp released AVP in rat (Koyuncuoğlu et al., 1984) .
In the light of information mentioned above, D-Asp causes a decrease in food intake probably due to the increased levels of AVP, endogeneous opioid and ACTH, respectively. When both AVP and ACTH were taken into consideration together with the actions of concomitantly released betalipotropin and beta-endorphin, which may affect loss of appetite being opioid, the body weight loss would be a quite natural result in the rat (Koyuncuoğlu et al., 1984) . Arginine vasotocin (AVT), the avian homologue of mammalian AVP, is also involved in the regulation of corticosterone release mediated through the function of ACTH (Castro et al., 1986) . D-Asp may release AVT in the chicken as observed in AVP by the mammal. In birds, there is limited information regarding the identification of opioid receptor subtypes. It was reported that under conditions in which birds had free access to food, DAMGO, a selective μ-opioid receptor agonist, decreased food intake of chicks (Bungo et al., 2004 (Bungo et al., , 2005 . Further experiment is necessary to clarify the mechanism.
In our previous report, i.c.v. injection of L-Asp or D-Asp clearly attenuated stress responses in chicks (Erwan et al., 2012) . In that study, both L-and D-Asp might directly act on the center for stress responses located in the diencephalon. On the other hand, in Experiment 1, L-Asp content in the diencephalon was not increased by oral administration of LAsp, while in Experiment 2, D-Asp content was increased after the oral administration of D-Asp. These differences between L-and D-Asp could be explained by the specificity of the mechanism of metabolism in D-Asp: the plasma DAsp concentration was elevated markedly (256-fold in the highest D-Asp group compared with the control group) when D-Asp was orally administrated, but the increase in plasma L-Asp was limited when L-Asp was orally administered. These findings strongly support previous research described by Maruyama et al. (1972) , who reported that free Asp concentration in plasma was elevated markedly when the DAsp content of the diet was increased to 2 or 3%, whereas values for chicks fed L-Asp did not change so much. The accumulation of D-Asp in the plasma pool of chicks might indicate that the capacity for oxidation of this amino acid is limited. These results suggest that the metabolism of D-Asp was very slow compared with that of L-Asp. Maruyama et al. (1972) have proved that the removal of D-Asp from the diet returns the plasma levels of Asp to normal in chicks. In the present study, the methods applied were limited, since the injection was done by gavage and narrow ranges of doses were applied. Further conditions should be applied to clarify the functions of L-and D-Asp in future.
When the focus was on monoamine levels in the brain, significant changes were only minimally observed in both the telencephalon and the diencephalon. In the present study, NE was not detectable, but HVA as DA metabolite and 5HT and 5HIAA were detected. These results may, at least in part, reflect release of their respective neurotransmitters (Gruss and Braun, 1997; Gruss et al., 1999) . Focusing on the variations in the basal values of DA content between the experiments, several studies (Saito et al., 2004; Shiraishi et al., 2010; Katayama et al., 2010 Katayama et al., , 2011 Erwan et al., 2012) have reported the fluctuation of monoamine contents especially in basal values of DA in the diencephalon or telencephalon in chicks. The reason of these differences was not clear. We conducted the same procedures when determined the monoamine contents. Due to these fluctuations among studies, we compared the data within experiments but not between experiments. However, to our knowledge there is no report of relationships between the L-or D-Asp and monoamines to explain the arousal effect of L-or D-Asp in neonatal chick. These results confirmed those of our previous study (Erwan et al., 2012) in which monoamine levels in the diencephalon and telencephalon were found not to be modified by i.c.v. injection of L-or D-Asp in chicks. On the other hand, several experiments have suggested that the stimulation of NMDA receptors is linked to the regulation of the monoaminergic system in the brain (Hanania and Zahniser, 2002; Karlsson et al., 2006; Hamasu et al., 2009) . Thus, it remains unclear whether there is a relationship between L-or D-Asp and the monoaminergic system, because monoamine levels in the brain do not always reflect the activity of their neurons. Furthermore, we only measured monoamine contents in the present study, and not monoamine release, which may be a more precise marker of monoamine neuronal activity. Further work focusing on the relationship between Asp and the monoaminergic system in the brain is necessary.
In conclusion, orally administered D-Asp, but not orally administered L-Asp, had a negative, depressive effect on food intake in neonatal chicks. D-Asp may control the feeding center without producing changes in the metabolism of monoamines.
